DaVita Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy DaVita Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for DaVita Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for DaVita Inc. is DVA:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
DaVita Inc. has its primary listing on New York Stock Exchange. You can trade DaVita Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, DaVita Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include DaVita Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like DaVita Inc..